0001213900-19-005664.txt : 20190402 0001213900-19-005664.hdr.sgml : 20190402 20190402201842 ACCESSION NUMBER: 0001213900-19-005664 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190402 DATE AS OF CHANGE: 20190402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Franck Amouyal CENTRAL INDEX KEY: 0001723469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52545 FILM NUMBER: 19727205 MAIL ADDRESS: STREET 1: 5 MAZEH ST. CITY: TEL AVIV STATE: L3 ZIP: 65213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wize Pharma, Inc. CENTRAL INDEX KEY: 0001218683 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880445167 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5B HANAGAR STREET CITY: HOD HASHARON STATE: L3 ZIP: 4527708 BUSINESS PHONE: 972 472 260 0536 MAIL ADDRESS: STREET 1: 5B HANAGAR STREET CITY: HOD HASHARON STATE: L3 ZIP: 4527708 FORMER COMPANY: FORMER CONFORMED NAME: OphthaliX, Inc. DATE OF NAME CHANGE: 20120207 FORMER COMPANY: FORMER CONFORMED NAME: DENALI CONCRETE MANAGEMENT INC DATE OF NAME CHANGE: 20030213 4 1 ownership.xml X0306 4 2019-03-31 0 0001218683 Wize Pharma, Inc. WIZP 0001723469 Franck Amouyal C/O WIZE PHARMA, INC. 5B HANAGAR STREET HOD HASHARON L3 4527708 ISRAEL 1 0 0 0 Restricted Stock Units (RSU) 2019-03-31 4 A 0 100000 0 A Common Stock 100000 100000 D Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. Vest quarterly over a two year period commencing on the date of grant. /s/ Or Eisenberg, Attorney-in-Fact 2019-04-02